D
Dyadic International, Inc. (Nasdaq: DYAI) - We are a global biotechnology company focused on further improving and leveraging the patented and proprietary C1 expression system to help bring biologic vaccines and drugs to market faster, in greater volumes, at lower cost, and with new properties to drug developers and manufacturers to improve access and cost to patients and the healthcare system - but most importantly to save lives.
Investor insights
Funding rounds participated in
$3M sweet spot round size
Investor type
Public Company
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
1979
Funding rounds raised
Total raised
$3M
from 1 investors over 1 rounds
D
Dyadic International, Inc. raised $3M on December 21, 2024
Investors: Bill & Melinda Gates Foundation